Evidence map›Paper›PMID 25726526›Full record

ArticleOncotarget2015

Nuclear-encoded cytochrome c oxidase subunit 4 regulates BMI1 expression and determines proliferative capacity of high-grade gliomas.

Claudia R Oliva, Tahireh Markert, G Yancey Gillespie, Corinne E Griguer

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 54 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. A Phyto-mycotherapeutic Supplement, NamelyInternational journal of molecular sciences · 2024
    Article
  12. Review
  13. Article
  14. Glioblastoma Metabolism: Insights and Therapeutic Strategies.International journal of molecular sciences · 2023
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Claudia R OlivaDepartment of Neurosurgery, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Tahireh MarkertDepartment of Neurosurgery, University of Alabama at Birmingham, Birmingham, Alabama, USA.
G Yancey GillespieDepartment of Neurosurgery, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Corinne E GriguerDepartment of Neurosurgery, University of Alabama at Birmingham, Birmingham, Alabama, USA.
University of Alabama at Birmingham · US

Funding

XRAY CRYSTALLOGRAPHYP30CA013148 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Robert S Welner · 1985 to 2026
$165.9M
Viral and molecular chemotherapy of malignant CNS tumorsP50CA097247 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI GILLESPIE, G. YANCEY · 2002 to 2009
$13.5M
CONTEMPORARY THERAPEUTICS FOR ANAPLASTIC GLIOMASP20CA151129 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI GILLESPIE, G. YANCEY · 2011 to 2013
$2.3M
Epigenetic regulation of temozolomide responsiveness in glioblastomaR01CA127716 · NCI · MAYO CLINIC ROCHESTER · PI SARKARIA, JANN N. · 2008 to 2012
$1.9M
Cytochrome C Oxidase in Malignant GliomasR01CA160821 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI GRIGUER, CORINNE E. · 2012 to 2016
$1.5M
Mitochondrial Dysfunction and Chemoresistance in Malignant GliomasR21CA139290 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI GRIGUER, CORINNE E. · 2010 to 2011
$346k
NCI NIH HHS P20 CA151129NCI NIH HHS P30 CA013148NCI NIH HHS P30 CA13148-35NCI NIH HHS P50 CA097247NCI NIH HHS R01 CA127716NCI NIH HHS R01 CA160821NCI NIH HHS R21 CA139290
6 · The paper itself

Abstract

Nuclear-encoded cytochrome c oxidase subunit 4 (COX4) is a key regulatory subunit of mammalian cytochrome c oxidase, and recent studies have demonstrated that COX4 isoform 1 (COX4-1) could have a role in glioma chemoresistance. The Polycomb complex protein BMI1 is a stem cell regulatory gene implicated in the pathogenesis of many aggressive cancers, including glioma. This study sought to determine if COX4 regulates BMI1 and modulates tumor cell proliferation. Using The Cancer Genome Atlas database and a retrospective data set from patients with glioblastoma multiforme, we found that BMI1 expression levels positively correlated with COX4-1 expression and overall survival. Whereas COX4-1 promoted cell growth by increasing BMI1 expression, COX4-2 inhibited cell growth even in cells overexpressing BMI1. We also demonstrate that COX4-1 attenuates mitochondrial reactive oxygen species (ROS) production, which is required for COX4-1-mediated effects on BMI1 expression and cell proliferation. Notably, mice bearing COX4-1-expressing glioma cell xenografts quickly developed invasive tumors characterized by the presence of multiple lesions positive for Ki-67, BMI1, and COX4-1, whereas mice bearing COX4-2-expressing xenografts rarely developed tumors by this point. COX4-1 also promoted the self-renewal of glioma stem-like cells, consistent with the reported role of BMI1 in stem cell growth. Taken together, these findings identify a novel COX4-1-mitochondrial ROS axis, in which differential expression of COX4 isoforms regulates mitochondrial ROS production and controls BMI1 expression.

Indexed as

AnimalsBlotting, WesternBrain NeoplasmsCell ProliferationCell RespirationElectron Transport Complex IVFemaleGene Expression Regulation, NeoplasticGliomaHeterograftsHumansImmunohistochemistryKaplan-Meier EstimateMiceMice, NudeMitochondriaBMI1 protein, humanElectron Transport Complex IVPolycomb Repressive Complex 1Reactive Oxygen Species

Identifiers

PMID25726526
PMCPMC4414193
OpenAlexW1541324451

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.